saikosaponin A, saikosaponin B, saikosaponin B1, saikosaponin B2, saikosaponin B3, saikosaponin B4, saikosaponin C, saikosaponin D, saikosaponin K, saikosaponin L, saikosaponins
Name | Saikosaponin D | ||
PubChem CID | 107793 | ||
Molecular Weight | 781.0g/mol | ||
Synonyms |
saikosaponin A, saikosaponin B, saikosaponin B1, saikosaponin B2, saikosaponin B3, saikosaponin B4, saikosaponin C, saikosaponin D, saikosaponin K, saikosaponin L, saikosaponins |
||
Formula | C₄₂H₆₈O₁₃ | ||
SMILES | CC1C(C(C(C(O1)OC2CCC3(C(C2(C)CO)CCC4(C3C=CC56C4(CC(C7(C5CC(CC7)(C)C)CO6)O)C)C)C)O)OC8C(C(C(C(O8)CO)O)O)O)O | ||
InChI | 1S/C42H68O13/c1-21-28(46)33(55-34-31(49)30(48)29(47)22(18-43)53-34)32(50)35(52-21)54-27-10-11-37(4)23(38(27,5)19-44)8-12-39(6)24(37)9-13-42-25-16-36(2,3)14-15-41(25,20-51-42)26(45)17-40(39,42)7/h9,13,21-35,43-50H,8,10-12,14-20H2,1-7H3/t21-,22-,23-,24-,25-,26-,27+,28+,29-,30+,31-,32-,33+,34+,35+,37+,38+,39-,40+,41-,42+/m1/s1 | ||
InChIKey | KYWSCMDFVARMPN-LCSVLAELSA-N | ||
CAS Number | 20874-52-6 | ||
ChEMBL ID | CHEMBL3613719 | ||
Toxicity | Organism | Test Type | Route(Dose) |
rat | LD50 | intraperitoneal(165 mg/kg) | |
mouse | LD50 | intraperitoneal(254 mg/kg) | |
rat | LD50 | oral(322 mg/kg) | |
Structure |
Download
2D
MOL
3D
MOL
|
Chineses Pinyin | ChaiHu | ||
Use Part | Root | ||
Habitat | HuBei, SiChuan, AnHui | ||
Flavor | Pungent, Bitter | ||
Meridian Tropism | Liver, Gallbladder, Lung | ||
Species |
>Kingdom: Viridiplantae
-->Phylum: Streptophyta
-->Class: Equisetopsida
-->Order: Apiales
-->Family: Apiaceae
-->Genus: Bupleurum
-->Species: Bupleurum scorzonerifolium
|
Chineses Pinyin | QianHu | ||
Use Part | Root | ||
Habitat | ZheJiang, HuNan, SiChuan | ||
Flavor | Bitter, Pungent | ||
Meridian Tropism | Lung | ||
Species |
>Kingdom: Viridiplantae
-->Phylum: Streptophyta
-->Class: Equisetopsida
-->Order: Apiales
-->Family: Apiaceae
-->Genus: Peucedanum
-->Species: Peucedanum praeruptorum
|
Chineses Pinyin | ZhuYeChaiHu | ||
Use Part | Root | ||
Habitat | SiChuan, GuiZhou, YunNan, XiZang, ChongQing, ShanXi, HeNan, AnHui, HuBei, HuNan, JiangXi | ||
Flavor | Bitter | ||
Meridian Tropism | Liver, Gallbladder | ||
Species |
>Kingdom: Viridiplantae
-->Phylum: Streptophyta
-->Class: Equisetopsida
-->Order: Apiales
-->Family: Apiaceae
-->Genus: Bupleurum
-->Species: Bupleurum marginatum
|
Chineses Pinyin | ZiHuaQianHu | ||
Use Part | Root | ||
Habitat | LiaoNing, HeBei, Shaanxi, HeNan, SiChuan, HuBei, AnHui, JiangSu, ZheJiang, JiangXi, GuangXi, GuangDong, TaiWan | ||
Flavor | Bitter, Pungent | ||
Meridian Tropism | Lung | ||
Species |
>Kingdom: Viridiplantae
-->Phylum: Streptophyta
-->Class: Equisetopsida
-->Order: Apiales
-->Family: Apiaceae
-->Genus: Angelica
-->Species: Angelica decursiva
|
Chineses Pinyin | DaYeChaiHu | ||
Use Part | Root | ||
Habitat | HuBei, SiChuan, AnHui | ||
Flavor | Bitter | ||
Meridian Tropism | Liver, Gallbladder, Lung |
Chineses Pinyin | HongChaiHu | ||
Use Part | Root | ||
Habitat | HeiLongJiang, JiLin, LiaoNing, HeBei, ShanDong, ShanXi, Shaanxi, JiangSu, AnHui, GuangXi, NeiMengGu, GanSu | ||
Flavor | Pungent, Bitter | ||
Meridian Tropism | Liver, Gallbladder | ||
Species |
>Kingdom: Viridiplantae
-->Phylum: Streptophyta
-->Class: Equisetopsida
-->Order: Apiales
-->Family: Apiaceae
-->Genus: Bupleurum
-->Species: Bupleurum scorzonerifolium
|
Chineses Pinyin | XiaoYeHeiChaiHu | ||
Use Part | Root | ||
Habitat | NeiMengGu, GanSu, NingXia, QingHai | ||
Flavor | Bitter | ||
Meridian Tropism | Lung, Heart, Liver, Gallbladder | ||
Species |
>Kingdom: Viridiplantae
-->Phylum: Streptophyta
-->Class: Equisetopsida
-->Order: Apiales
-->Family: Apiaceae
-->Genus: Bupleurum
-->Species: Bupleurum smithii
|
Pair Name | Saikosaponin D, Gefitinib | |||
Partner Name | Gefitinib | |||
Disease Info | [ICD-11: 2C25.Z] | Lung cancer | Investigative | |
Biological Phenomena | Induction-->Apoptosis | |||
Gene Regulation | Down-regulation | Phosphorylation | STAT3 | hsa6774 |
Down-regulation | Expression | BCL2 | hsa596 | |
In Vitro Model | NCI-H1975 | Lung adenocarcinoma | Homo sapiens (Human) | CVCL_1511 |
HCC827 | Lung adenocarcinoma | Homo sapiens (Human) | CVCL_2063 | |
PC-9 | Lung adenocarcinoma | Homo sapiens (Human) | CVCL_B260 | |
HCC827-GR-high1 | Lung adenocarcinoma | Homo sapiens (Human) | CVCL_S703 | |
Hep-G2 | Hepatoblastoma | Homo sapiens (Human) | CVCL_0027 | |
In Vivo Model | Mice were intraperitoneally injected with HCC827/GR (1×10⁷) cells in the dorsal region. | |||
Result | These results indicated that the combination of SSD with gefitinib had an increased antitumor effect in NSCLC cells and that the molecular mechanisms were associated with the inhibition of STAT3/Bcl-2 signaling pathway. Our findings suggest a promising approach for the treatment of NSCLC patients with EGFR-TKI resistance. |
Pair Name | Saikosaponin D, 1,9-Pyrazoloanthrone | |||
Partner Name | 1,9-Pyrazoloanthrone | |||
Disease Info | [ICD-11: 2B51] | Osteosarcoma | Investigative | |
Biological Phenomena | Induction-->Mitochondria-mediated apoptosis | |||
Gene Regulation | Down-regulation | Phosphorylation | AKT1 | hsa207 |
Up-regulation | Expression | BAX | hsa581 | |
Down-regulation | Expression | BCL2 | hsa596 | |
Up-regulation | Expression | CASP3 | hsa836 | |
In Vitro Model | U2OS | Osteosarcoma | Homo sapiens (Human) | CVCL_0042 |
Result | A dramatic inhibition of cellular proliferation, invasion, and migration in cells treated with Ssd alone or in combination with SP600125 was observed |
Pair Name | Saikosaponin D, Cisplatin | |||
Partner Name | Cisplatin | |||
Disease Info | [ICD-11: 2A00-2F9Z] | Solid tumour or cancer | Investigative | |
Biological Phenomena | Induction-->ROS-mediated apoptosis | |||
Gene Regulation | Up-regulation | Cleavage | CASP3 | hsa836 |
Up-regulation | Cleavage | PARP1 | hsa142 | |
In Vitro Model | HeLa | Human papillomavirus-related cervical adenocarcinoma | Homo sapiens (Human) | CVCL_0030 |
Result | These results suggest that saikosaponins sensitize cancer cells to cisplatin through ROS-mediated apoptosis, and the combination of saikosaponins with cisplatin could be an effective therapeutic strategy. |
Pair Name | Saikosaponin D, Gefitinib | |||
Partner Name | Gefitinib | |||
Disease Info | [ICD-11: 2C12] | Hepatocellular carcinoma | Investigative | |
Biological Phenomena | Inhibition-->Glycolysis | |||
Gene Regulation | Down-regulation | Expression | ADRB2 | hsa154 |
Down-regulation | Expression | HK2 | hsa3099 | |
Down-regulation | Expression | SLC2A1 | hsa6513 | |
Down-regulation | Expression | ABCC1 | hsa4363 | |
Down-regulation | Expression | ABCG2 | hsa9429 | |
Down-regulation | Expression | SLC2A1 | hsa6513 | |
Down-regulation | Expression | HK2 | hsa3099 | |
In Vitro Model | RBE | Intrahepatic cholangiocarcinoma | Homo sapiens (Human) | CVCL_4896 |
HuCC-T1 | Intrahepatic cholangiocarcinoma | Homo sapiens (Human) | CVCL_0324 | |
Result | Saikosaponin D enhances the antitumor effect of gemcitabine by controlling glucose metabolism and drug efflux by inhibiting the ADRB2 signaling. Therefore, the combination of saikosaponin D and gemcitabine may be a potential therapeutic strategy for the treatment of iCCA. |
No. | Title | Href |
---|---|---|
1 | The Effects and Mechanisms by which Saikosaponin-D Enhances the Sensitivity of Human Non-small Cell Lung Cancer Cells to Gefitinib. J Cancer. 2019 Oct 22;10(26):6666-6672. doi: 10.7150/jca.30361. | Click |
2 | Use of Saikosaponin D and JNK inhibitor SP600125, alone or in combination, inhibits malignant properties of human osteosarcoma U2 cells. Am J Transl Res. 2019 Apr 15;11(4):2070-2080. | Click |
3 | Reactive oxygen species-mediated apoptosis contributes to chemosensitization effect of saikosaponins on cisplatin-induced cytotoxicity in cancer cells. J Exp Clin Cancer Res. 2010;29(1):159. Published 2010 Dec 9. doi:10.1186/1756-9966-29-159 | Click |
4 | Saikosaponin D reverses epinephrine- and norepinephrine-induced gemcitabine resistance in intrahepatic cholangiocarcinoma by downregulating ADRB2/glycolysis signaling. Acta Biochim Biophys Sin (Shanghai). 2023 Jul 25;55(9):1404-1414. doi: 10.3724/abbs.2023040. | Click |